News | Ultrasound Intra-cardiac Echo (ICE) | July 16, 2021

Mayo Clinic First to Use Next Generation 4D ICE System to Guide Structural Heart Procedures

Intracardiac echo enables reduced need for general anesthesia accelerates workflows, increases efficiency and broadens treatment options

ICE image showing the inside of the heart. Mayo Clinic recently became the first to use the next-generation Philips 4-D intracardiac echo imaging catheter. ICE is seeing increased use in structural heart procedures.

ICE image showing the inside of the heart. Mayo Clinic recently became the first to use the next-generation Philips 4-D intracardiac echo imaging catheter. ICE is seeing increased use in structural heart procedures.


July 16, 2021 — Mayo Clinic recently became the first to use a next-generation 4-D intracardiac echo (ICE) imaging device in a patient to guide a transcatheter left atrial appendage (LAA) closure at Mayo Clinic.

The new Philips Healthcare VeriSight Pro ICE catheter offers superior 2-D and 3-D live image guidance for a wide range of procedures in structural heart disease and electrophysiology, allowing interventionalists to navigate procedures. It can be used to help guide transcatheter mitral valve repair (TMVR) and treatment of tricuspid valve regurgitation. The technology can also help physicians perform procedures without putting patients under general anesthesia.

Live ultrasound imaging during structural heart disease and electrophysiology procedures typically relies on transesophageal echocardiography (TEE) imaging, in which an ultrasound probe is passed down the patient’s throat and into their esophagus, until it lies next to the heart. TEE requires the patient to be sedated or given general anesthesia, lengthening preparation, procedure and recovery times and carrying a degree of risk. Philips’ ICE catheter VeriSight Pro uses the same ultrasound technology, miniaturized to fit on the tip of a 3 mm diameter (9 French) catheter so that it can be navigated to the patient’s heart via their vasculature using the same route used to introduce other catheters during minimally-invasive cardiac interventions. General anesthesia is typically not required, reducing patient risk, and opening up procedures to patients who are not good anesthesia candidates.

"The next generation 4-D ICE technology can transform how we perform some complex transcatheter interventions. For example, it facilitates the performance of left atrial appendage closure under moderate sedation, making the procedure accessible to many patients who are not good candidates for general anesthesia. It also provides excellent imaging of the tricuspid valve, allowing of a more effective transcatheter treatment of tricuspid regurgitation," explains Mohamad Adnan Alkhouli, M.D., an interventional cardiologist at Mayo Clinic in Rochester.

The new Philips Healthcare VeriSight Pro ICE catheter offers superior 2-D and 3-D live image guidance for a wide range of procedures in structural heart disease and electrophysiology, allowing interventionalists to navigate procedures.The new 4-D echo catheter, which is small enough to be inserted into the heart chambers, uses advanced imaging technology to create high-quality 3-D moving images. This technology allows physicians to see structures and blood flow in live motion inside the heart, which is a major improvement over the standard intracardiac echo catheters that are only capable of providing 2-D images.

This in-motion view from inside the heart provides useful information for clinicians, especially in areas of the heart that are difficult to adequately view via transthoracic or transesophageal echo. The 4-D technology provides greater visual details to guide interventional heart procedures, such as left atrial appendage closure, mitral valve repair and treatment of tricuspid valve regurgitation. Also, the 4D echo does not require the patient to be under anesthesia, which is important for patients with sedation sensitivities.

In June 2021, Alkhouli performed the first series of in-person transcatheter interventions at Mayo using 4-D ICE imaging and is working to create standardized imaging protocols for ICE-guided structural heart procedures.

"Mayo Clinic continues to be on the forefront of novel technologies that expand access to care for our growing population of patients with structural heart diseases," Alkhouli said.

For interventional cardiologists, VeriSight Pro delivers a good alternative high quality 3-D live image to TEE, including 3-D Volume and color flow Doppler imaging. Based on Philips’ innovative xMatrix 3D ultrasound transducer technology, Verisight Pro can provide a 90 by 90 degree 3-D field of view as well as allowing physicians to view two scan planes simultaneously. For example, the long and short axes of the LAA to select the appropriately sized device for LAA closure. VeriSight Pro provides superior 2-D ICE imaging, as well as the ability to access new views more easily. Interventionalists can digitally change the scan angle to capture views without manually repositioning the ultrasound tip, a unique feature of this ICE catheter.

The VeriSight Pro is designed to be used with Philips Epiq CVx. The new ICE catheter is available on a limited basis in the U.S.

For more information: www.usa.philips.com/healthcare

 

Related Intra-cardiac Echo Content:

Northwestern Medicine First in U.S. to Use Live 3D Intracardiac Echo for EP Procedure

Mayo Clinic First to Use Next Generation 4D ICE System to Guide Structural Heart Procedures

Trends and Advancements in Intra-cardiac Echo Imaging Systems

Intra-Cardiac Echo Aids EP Ablations, Structural Heart Procedures

Intracardiac Echo Should be More Widely Adopted to Minimize Radiation in Catheter Ablations

Conavi Medical Receives FDA Clearance for Feature Expansion on Foresight Intracardiac Echocardiography System

Find more ICE content

 

Related Content

News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Cath Lab

November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...

Home November 10, 2021
Home
Subscribe Now